Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
Wall Street Journal
The deal expands the pharmaceutical company’s portfolio of cancer drugs.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The deal expands the pharmaceutical company’s portfolio of cancer drugs.